Do regulatory T Cells Contribute to Th1 Skewness in Obesity?

Abstract

Background: Recent data suggest that an increased prevalence of interferon-gamma (IFN-γ) producing CD4⁺ cells is present in obesity. Regulatory T cells (Tregs) have a strong impact on activation and proliferation of CD4⁺ lymphocytes. Data are not available about Tregs and their possible contribution to chronic mild inflammation in obesity.

Design: We investigated the prevalence of Tregs in obese children. We also collected data about dendritic cells and monocytes (so-called antigen presenting cells, APCs), important modulators of Tregs and we determined the cytokine production of CD4⁺ lymphocytes, the main target cells of Tregs.

Methods: Twelve obese children and 10 healthy age-matched controls have been enrolled. For flow cytometric analyses, peripheral blood mononuclear cells were used. We determined the prevalence of Tregs by Foxp3 expression of CD4⁺ cells; prevalence of myeloid and plasmacytoid dendritic cells (DCs); prevalence of tumor necrosis factor (TNF)-α and interleukin(IL)-12 producing monocytes; and prevalence of IL-2, IL-4 and IFN-γ producing CD4⁺ cells.

Results: The prevalence of Tregs, DCs, TNF-α and IL-12 producing macrophages, IL-2 and IFN-γ producing CD4⁺ cells was similar in both groups. The prevalence of IL-4 producing CD4⁺ cells was lower in obese children than in healthy controls (p=0.028). The ratio of IFN-γ⁺/ IL-4⁺ CD4⁺ cells was higher in obese children than in those with normal weight (p=0.046).

Conclusions: CD4⁺ reactions are polarized toward Th1 direction in obesity. The unaltered number of Treg and APCs suggests that these immune regulator cells do not contribute to altered immune status in obese children.

Key words

Obesity - regulatory T cell - Foxp3 - Th1 - cytokine - dendritic cell - monocyte

References

• 1 Ait-Oufella H, Salomon BL, Potteaux S, Robertson AK, Gourdy P, Zoll J, Merval R, Esposito B, Cohen JL, Fisson S, Flavell RA, Hansson GK, Klatzmann D, Tedgui A, Mallat Z. Natural regulatory T cells control the development of atherosclerosis in mice.  Nat Med. 2006;  12 178-180
• 2 Ardavin C, Martinez del Hoyo G, Martin P, Anjuere F, Arias CF, Marin AR, Ruiz S, Parrillas V, Hernandez H. Origin and differentiation of dendritic cells.  Trends Immunol. 2001;  22 691-700
• 3 Baecher-Allan C, Hafler DA. Suppressor T cells in human diseases.  J Exp Med. 2004a;  200 273-276
• 4 Baecher-Allan C, Viglietta V, Hafler DA. Human CD4⁺CD25⁺ regulatory T cells.  Semin Immunol. 2004b;  16 89-98
• 5 Bellinghausen I, Klostermann B, Knop J, Saloga J. Human CD4⁺CD25⁺ T cells derived from the majority of atopic donors are able to suppress TH1 and TH2 cytokine production.  J Allergy Clin Immun. 2005;  111 862
• 6 Chatila TA. Role of regulatory T cells in human diseases.  J Allergy Clin Immun. 2005;  116 949-959
• 7 Cederbom L, Hall H, Ivars F. CD4⁺CD25⁺ regulatory T cells down-regulate costimulatory molecules on antigen-presenting cells.  Eur J Immunol. 2000;  30 1538-1543
• 8 Cosmi L, Liotta F, Angeli R, Mazzinghi B, Santarlasci V, Manetti R, Lasagni L, Vanini V, Romagnani P, Maggi E, Annunziato F, Romagnani S. Th2 cells are less susceptible than Th1 cells to the suppressive activity of CD25⁺ regulatory thymocytes because of their responsiveness to different cytokines.  Blood. 2004;  103 3117-3121
• 9 Das UN. Is obesity an inflammatory condition?.  Nutrition. 2001;  17 953-966
• 10 Dejaco C, Duftner C, Grubeck-Loebenstein B, Schirmer M. Imbalance of regulatory T cells in human autoimmune diseases.  Immunology. 2006;  117 289-300
• 11 Fantuzzi G. Adipose tissue, adipokines, and inflammation.  J Allergy Clin Immun. 2005;  115 911-919
• 12 Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4⁺CD25⁺ regulatory T cells.  Nat Immunol. 2003;  4 330-336
• 13 Gonzalez F, Minium J, Rote NS, Kirwan JP. Altered tumor necrosis factor alpha release from mononuclear cells of obese reproductive-age women during hyperglycemia.  Metabolism. 2006;  55 271-276
• 14 Groux H, Fournier N, Cottrez F. Role of dendritic cells in the generation of regulatory T cells.  Semin Immunol. 2004;  16 99-106
• 15 Hawrylowicz CM, O’Garra A. Potential role of interleukin-10-secreting regulatory T cells in allergy and asthma.  Nat Rev Immunol. 2005;  5 271-283
• 16 Houot R, Perrot I, Garcia E, Durand I, Lebecque S. Human CD4⁺CD25high regulatory T cells modulate myeloid but not plasmacytoid dendritic cells activation.  J Immunol. 2006;  176 5293-5298
• 17 Ito T, Kanzler H, Duramad O, Cao W, Liu YJ. The specialization, kinetics, and repertoire of type I interferon responses by human plasmacytoid pre-dendritic cells.  Blood. 2006;  107 2423-2431
• 18 Kadowaki N, Ho S, Antonenko S, Malefyt RW, Kastelein RA, Bazan F, Liu YJ. Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens.  J Exp Med. 2001;  194 863-869
• 19 Mallat Z, Gojova A, Brun V, Esposito B, Fournier N, Cottrez F, Tedgui A, Groux H. Induction of a regulatory T cell type 1 response reduces the development of atherosclerosis in apolipoprotein E-knockout mice.  Circulation. 2003;  108 1232-1237
• 20 Mattioli B, Straface E, Quaranta MG, Giordani L, Viora M. Leptin promotes differentiation and survival of human dendritic cells and licenses them for Th1 priming.  J Immunol. 2005;  174 6820-6828
• 21 Misra N, Bayry J, Lacroix-Desmazes S, Kazatchkine MD, Kaveri SV. Cutting edge: human CD4⁺CD25⁺ t cells restrain the maturation and antigen-presenting function of dendritic cells.  J Immunol. 2004;  172 4676-4680
• 22 Moseman EA, Liang X, Dawson AJ, Panoskaltsis-Mortari A, Krieg AM, Liu YJ, Blazar BR, Chen W. Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4⁺CD25⁺ regulatory T cells.  J Immunol. 2004;  173 4433-4442
• 23 Naranjo-Gomez M, Fernandez MA, Bofill M, Singh R, Navarrete CV, Pujol-Borrell R, Borras FE. Primary Alloproliferative TH1 response induced by immature plasmacytoid dendritic cells in collaboration with myeloid DCs.  Am J Transplant. 2005;  5 2838-2848
• 24 Orentas RJ, Kohler ME, Johnson BD. Suppression of anti-cancer immunity by regulatory T cells: back to the future.  Semin Cancer Biol. 2006;  16 137-149
• 25 Ouchi N, Kihara S, Funahashi T, Matsuzawa Y, Walsh K. Obesity, adiponectin and vascular inflammatory disease.  Curr Opin Lipidol. 2003;  14 561-566
• 26 Pacifico L, Di Renzo L, Anania C, Osborn JF, Ippoliti F, Schiavo E, Chiesa C. Increased T-helper interferon-{gamma}-secreting cells in obese children.  Eur JEndocrinol. 2006;  154 691-697
• 27 Reinehr T, Stoffel-Wagner B, Roth CL, Andler W. High-sensitive C-reactive protein, tumor necrosis factor alpha, and cardiovascular risk factors before and after weight loss in obese children.  Metabolism. 2005;  54 1155-1161
• 28 R Development Core Team. R . A language and environment for statistical computing.  , R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0, URL http://www.R-project.org 2006; 
• 29 Rutella S, Danese S, Leone G. Tolerogenic dendritic cells: Cytokine modulation comes of age.  Blood. 2006;  108 1435-1440 , [Epub ahead of print May 9]
• 30 Samocha-Bonet D, Lichtenberg D, Tomer A, Deutsch V, Mardi T, Goldin Y, Abu-Abeid S, Shenkerman G, Patshornik H, Shapira I, Berliner S. Enhanced erythrocyte adhesiveness/aggregation in obesity corresponds to low-grade inflammation.  Obes Res. 2003;  11 403-407
• 31 Shi HZ, Qin XJ. CD4CD25 regulatory T lymphocytes in allergy and asthma.  Allergy. 2005;  60 986-995
• 32 Taylor JJ, Mohrs M, Pearce EJ. Regulatory T cell responses develop in parallel to the responses and control the magnitude and phenotype of the th effector population.  J Immunol. 2006;  176 5839-5847
• 33 Trayhurn P, Wood IS. Adipokines: inflammation and the pleiotropic role of white adipose tissue.  Brit J Nutr. 2004;  92 347-355
• 34 Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. Low-grade systemic inflammation in overweight children.  Pediatrics. 2001;  107 E13
• 35 Visser M, Bouter LM, MacQuillan GM, Wener MH, Harris TB. Elevated C-reactive protein levels in overweight and obese adults.  JAMA. 1999;  282 2131-2135
• 36 Yokota T, Oritani K, Takahashi I, Ishikawa J, Matsuyama A, Ouchi N, Kihara S, Funahashi T, Tenner AJ, Tomiyama Y, Matsuzawa Y. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages.  Blood. 2000;  96 1723-1732

1 Institution to which the work should be attributed: Research Group of Pediatrics and Nephrology, Hungarian Academy of Sciences, Bókay u. 53, Budapest H-1083, Hungary

Correspondence